Tryp Therapeutics Inc.
from OTCQB Podcast
Tryp Therepeutics Inc. (OTCQB: TRYPF) is a pharmaceutical company focused on developing psilo-cybin-based compounds to treat diseases with unmet medical needs through accelerated regulatory pathways. CEO and Chief Scientific Officer joins us to discuss the company's drug development programs and the types of disorders it's currently targeting. View Podcast Transcript
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 9 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on June 12, 2023.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.